News
Video
The Impact of Congenital Plasminogen Deficiency on the Gynecologic System
Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, discusses the disease impact on the gynecologic system and how often patients become infertile due to this impact.
Pharmacy Times® interviewed Per Morten Sandset, MD, a principal investigator and professor in the Department of Haematology and the Research Institute of Internal Medicine at the University of Oslo and Oslo University Hospital, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research conducted to investigate the successful pregnancy of a patient with infertility due to congenital plasminogen deficiency who was treated with intravenous plasminogen replacement therapy.
In this video, Sandset discusses the disease impact on the gynecologic system and how often patients become infertile due to this impact.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
